..., instructions or products referred to in the content or advertisements. 2024 Visual Abstract Cardiovascular disease Hemodialysis Hypertension Left ventricular hypertrophy Sacubitril/valsartan The left ventricular hypertrophy (LVH) is a critical factor in the development of cardiac...

... and blood biochemical indicators were underestimated in patients with DKD undergoing hemodialysis. Therefore, we primarily aimed to investigate the glycemic variability and 1-year risk of cardiovascular disease events in diabetic hemodialysis patients. And we secondarily aimed to explore the association...

...Reiko Muto; Sawako Kato; Bengt Lindholm; Abdul Rashid Qureshi; Takuji Ishimoto; Tomoki Kosugi; Shoichi Maruyama Introduction: In dialysis patients, cardiovascular disease (CVD) and infectious disease contribute to poor clinical outcomes. We investigated if a higher monocyte/lymphocyte ratio (MLR...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Hemodialysis Cardiovascular disease Drug-eluting stent Stenosis Vascular calcification Cardiovascular disease is the principal cause of death in patients on hemodialysis (HD) [1-3...

.... Hemodialysis Soluble suppression of tumorigenicity-2 Cardiac risk Cardiac troponins Cardiovascular disease Cardiovascular disease (CVD) is a major complication and the first cause of death in patients with end-stage renal disease (ESRD) on hemodialysis (HD), with a mortality approximately 10–20...

... of peritoneal dialysis (PD) and the study is not yet clear. This study will analyze the effects of hypomagnesemia on all-cause, cardiovascular diseases (CVD), and non-CVD mortality in PD patients. Method: In a retrospective cohort study, 1,004 samples were selected from 7 PD centers in China. Based...

...Manuel Alfredo Podestà; Federica Valli; Andrea Galassi; Matthias A. Cassia; Paola Ciceri; Lucia Barbieri; Stefano Carugo; Mario Cozzolino Cardiovascular disease is a frequent complication and the most common cause of death in patients with CKD. Despite landmark medical advancements, mortality due...

... to in the content or advertisements. Soluble ST2 Cardiac remodeling Cardiovascular disease Hemodialysis Left ventricular hypertrophy Cardiovascular diseases are the main cause of morbidity and mortality in maintenance hemodialysis (MHD) patients [ 1, 2 ]. Left ventricular hypertrophy (LVH...

.... Apheresis C-reactive protein Cardiovascular disease Post-procedural course ST segment elevation myocardial reinfarction C-reactive protein (CRP) is the classical acute-phase protein that mediates secondary damage of the myocardial cells during acute myocardial infarction by activating...

... to the increased cardiovascular disease burden in this high-risk population. Methods: Intradialytic calcium kinetics was evaluated in a cross-sectional observational study by measuring dialysate-sided ionized calcium mass balance (iCa MB ), calcium buffer capacity, and change in serum calcium levels in 40 chronic...

...Masataka Banshodani; Hideki Kawanishi; Misaki Moriishi; Sadanori Shintaku; Shinichiro Tsuchiya Introduction: In patients with end-stage kidney disease (ESKD), cardiovascular diseases (CVDs) are the most common causes of hospitalization and death. Objective: We aimed to determine the association...

...Rupesh Raina; Claire Young; Vinod Krishnappa; Rahul Chanchlani Background and Aim: Elevated low-density lipoprotein cholesterol and/or lipoprotein(a) are established risk factors for cardiovascular disease (CVD). Management of hypercholesterolemia consists of drug therapies, including statins...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Combination therapy with peritoneal dialysis and hemodialysis Cardiac function Cardiovascular disease End-stage kidney disease End-stage renal disease Peritoneal...

... period was December 31, 2017. Cardiovascular disease Cardiovascular event End-stage kidney disease End-stage renal disease Frequent hemodialysis In end-stage kidney disease (ESKD) patients, the intermittency of conventional hemodialysis (HD) therapy has led to drastic changes...

...Teresa Jerónimo; Anabela Malho Guedes; Gloria del Peso; Ana Paula Silva; Rafael Selgas; Maria Auxiliadora Bajo; Pedro Leão Neves Background/Aims: Peritoneal protein loss (PPL) is associated with cardiovascular disease and mortality in peritoneal dialysis (PD). Controversial results have been...

... are the pathophysiological pathways by which acute heart failure may result in acute kidney injury (AKI; type 1), chronic heart failure accelerating the progression of chronic kidney disease (CKD; type 2), AKI provoking cardiac events (type 3), and CKD increasing the risk and severity of cardiovascular disease (type 4...

... a median follow-up of 22.1 months, 24% patients died, 61.4% of them due to cardiovascular disease (CVD). Anuric patients with faster transport were associated with an increased risk of all-cause mortality (HR (95% CI) = 2.16 (1.09-4.26)), but not cardiovascular mortality, after adjustment for confounders...

.... Abdominal aortic calcification Soluble Klotho Maintenance hemodialysis Cardiovascular disease Vascular calcification Cardiovascular disease (CVD) is one of the main causes of mortality in end-stage renal disease (ESRD) patients. Several studies suggested that vascular calcifications play a main...

... dietary sodium and both blood pressure and cardiovascular disease. Methods: Literature review of the available observational studies and randomized controlled trials, including systematic reviews and meta-analyses. Results: A large body of evidence from observational studies and clinical trials documents...

...Ivana Mikolasevic; Lidija Orlic; Sandra Milic; Luka Zaputovic; Vesna Lukenda; Sanjin Racki Background/Aims: Cardiovascular diseases (CVD) are the leading cause of mortality in hemodialysis (HD) patients. Recently, non-alcoholic fatty liver disease (NAFLD) has been recognized as a new risk factor...